SCN Applies for Listing on Oslo Axess

Scandinavian Clinical Nutrition i Sverige AB (SCN) has applied for listing on the Oslo Axess list on Oslo Börs. Oslo Börs today confirmed on their website that the application has been received.

”As SCN sees it, Oslo Börs is growing in importance as a trading site for companies working with research and development of nutraceuticals and that have international ambitions. Several companies with a clear focus on nutraceuticals are already listed on Oslo Börs, for example Aker BioMarine, Navamedic and Biotec Pharmacon, and SCN sees a great value in being a part of this development”, says Ulf Söderberg, CEO of SCN.

The notice from Oslo Börs can be read on their website by the following link:
http://www.newsweb.no/index.jsp?messageId=160358

Oslo Börs will now consider the application, and the listing is estimated to take place in November/December 2007.